SEC Form 4 · accession 0001179110-16-024509
Allergan plc · AGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nesli Basgoz
Director
Period of report
May 11, 2016
Accepted (ET)
May 12, 2016 · 7:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001578845
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value $0.0001 | May 11, 2016 | M | 459 | $82.53 | A | 5,242 | D | |
| Ordinary Shares, par value $0.0001F1 | May 11, 2016 | S | 459 | $225.10 | D | 4,783 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $82.53 | May 11, 2016 | M | 459 | D | — | May 18, 2016 | Ordinary Shares | 459 | 459 | D |
Explanation of responses
- F1Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc.
- F2This option became vested and exercisable in four equal installments commencing on May 18, 2006.